| Neurobiological links between depression and AD: the role of TGF-β1 signaling as a new pharmacological target F Caraci, SF Spampinato, MG Morgese, F Tascedda, MG Salluzzo, ... Pharmacological research 130, 374-384, 2018 | 157 | 2018 |
| The immune system on the TRAIL of Alzheimer’s disease C Burgaletto, A Munafò, G Di Benedetto, C De Francisci, F Caraci, ... Journal of Neuroinflammation 17, 1-11, 2020 | 58 | 2020 |
| Fluoxetine prevents Aβ1-42-induced toxicity via a paracrine signaling mediated by transforming-growth-factor-β1 F Caraci, F Tascedda, S Merlo, C Benatti, SF Spampinato, A Munafò, ... Frontiers in pharmacology 7, 230004, 2016 | 55 | 2016 |
| Role of Microglia and Astrocytes in Alzheimer’s Disease: From Neuroinflammation to Ca2+ Homeostasis Dysregulation G Di Benedetto, C Burgaletto, CM Bellanca, A Munafò, R Bernardini, ... Cells 11 (17), 2728, 2022 | 52 | 2022 |
| Ampicillin Plus Ceftriaxone Regimen against Enterococcus faecalis Endocarditis: A Literature Review A Marino, A Munafò, A Zagami, M Ceccarelli, R Di Mauro, G Cantarella, ... Journal of clinical medicine 10 (19), 4594, 2021 | 27 | 2021 |
| Stem cells: innovative therapeutic options for neurodegenerative diseases? G Bonaventura, A Munafò, CM Bellanca, V La Cognata, R Iemmolo, ... Cells 10 (8), 1992, 2021 | 24 | 2021 |
| Targeting the miRNA-155/TNFSF10 network restrains inflammatory response in the retina in a mouse model of Alzheimer’s disease C Burgaletto, CBM Platania, G Di Benedetto, A Munafò, G Giurdanella, ... Cell death & disease 12 (10), 905, 2021 | 23 | 2021 |
| Sarilumab administration in COVID-19 patients: literature review and considerations A Marino, A Munafò, E Augello, CM Bellanca, C Bonomo, M Ceccarelli, ... Infectious Disease Reports 14 (3), 360-371, 2022 | 18 | 2022 |
| Repositioning of immunomodulators: a ray of hope for Alzheimer’s disease? A Munafò, C Burgaletto, G Di Benedetto, M Di Mauro, R Di Mauro, ... Frontiers in Neuroscience 14, 614643, 2020 | 18 | 2020 |
| Intravenous fosfomycin: A potential good partner for cefiderocol. Clinical experience and considerations A Marino, S Stracquadanio, E Campanella, A Munafò, M Gussio, ... Antibiotics 12 (1), 49, 2022 | 14 | 2022 |
| Psilocybin for Depression: From Credibility to Feasibility, What’s Missing? A Munafò, D Arillotta, G Mannaioni, F Schifano, R Bernardini, ... Pharmaceuticals 16 (1), 68, 2022 | 10 | 2022 |
| In search of an ideal drug for safer treatment of obesity: The false promise of pseudoephedrine A Munafò, S Frara, N Perico, R Di Mauro, M Cortinovis, C Burgaletto, ... Reviews in Endocrine and Metabolic Disorders 22 (4), 1013-1025, 2021 | 10 | 2021 |
| TRAIL-R deficient mice are protected from neurotoxic effects of amyloid-β G Di Benedetto, C Burgaletto, MF Serapide, R Caltabiano, A Munafò, ... International Journal of Molecular Sciences 23 (19), 11625, 2022 | 7 | 2022 |
| Lights and shadows on managing immune checkpoint inhibitors in oncology during the COVID-19 era C Burgaletto, O Brunetti, A Munafò, R Bernardini, N Silvestris, ... Cancers 13 (8), 1906, 2021 | 7 | 2021 |
| Sarilumab administration in patients with severe COVID‑19: A report of four cases and a literature review A Marino, E Campanella, M Ceccarelli, L Larocca, C Bonomo, C Micali, ... World Academy of Sciences Journal 4 (4), 1-7, 2022 | 5 | 2022 |
| Ampicillin plus ceftriaxone therapy against Enterococcus faecalis endocarditis: A case report, guidelines considerations, and literature review A Marino, A Munafò, A Zagami, M Ceccarelli, E Campanella, F Cosentino, ... IDCases 28, e01462, 2022 | 5 | 2022 |
| Beneficial Effects of Choline Alphoscerate on Amyloid-β Neurotoxicity in an In Vitro Model of Alzheimer’s Disease C Burgaletto, G Di Benedetto, A Munafò, R Bernardini, G Cantarella Current Alzheimer Research 18 (4), 298-309, 2021 | 5 | 2021 |
| On the Management of Drug Interactions in the Course of Concomitant Treatments for COVID-19 and Antineoplastic Agents N Silvestris, A Munafò, O Brunetti, C Burgaletto, L Scucces, R Bernardini Frontiers in Oncology 10, 1340, 2020 | 4 | 2020 |
| Pharmacological enhancement of cholinergic neurotransmission alleviates neuroinflammation and improves functional outcomes in a triple transgenic mouse model of Alzheimer’s disease A Munafò, AF Cantone, G Di Benedetto, SA Torrisi, C Burgaletto, ... Frontiers in Pharmacology 15, 1386224, 2024 | 1 | 2024 |
| Taming Microglia in Alzheimer’s Disease: Exploring Potential Implications of Choline Alphoscerate via α7 nAChR Modulation AF Cantone, C Burgaletto, G Di Benedetto, A Pannaccione, A Secondo, ... Cells 13 (4), 309, 2024 | 1 | 2024 |
